Cell Wall Inhibitors Flashcards

1
Q

Penicillin G & V spectrum

A

Gram (+) microbes have the greatest activity
gram (-) cocci -> not as good because need to get through cell wall where B-lactamase is waiting
and non-B-lactamase producing anaerobes
Susceptible to B-lactamase activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

B-lactamase resistant penicillins spectrum

A

Nafcillin, Dicloxacilliin
Against Strep, staph, pneunmococci
No activity against enterococci and anaerobes or gram (-) rods or cocci

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aminopenicillins and extended spectrum penicillins

A

amoxicillin, ampicillin
similar to penicillin in spectrum
BUT WITH GREATER ACTIVITY AGAINST GRAM (-)
often with B-lactamase inhibitors like clavulanic acid (increases the activity of the abx)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indication and drug of choice for Penicillin G

A

Streptococci, Meningococci, PEN- susceptible pneumococci

for Antrax, diptheria, C. difficile, syphillis, meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Indication and drug of choice for Penicillin V

A

Poor availability -> mild infections
Step. A,C,G (pharyngitis and tonsilitis)
PEN -sensitive S. pneumonaie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical uses for Nafcillin and Dicloxacillin - B-lactamase resistant

A

Penicillnase producing staph,
MSSA - methicillin susceptible s. aureus
prosthetic valve infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aminopenicillins - ampicillin and amoxicillin

A

drug of choice for pneumococci
shigella and other GI infections
Gonorrhea
Respiratory infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ticarcillin, Piperacillin, Azlocillin - extended spectrum

A
drug of choice for pseudomonas
also for shigella and other GI
bone and joint infections
skin infections
also used for lower respiratory and UTI where access is difficult
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MoA of penicillins and cephalosporins

A

Inhibit transpeptidase PBP1a and PBP1b -> prevents D-ala removal on the 5th position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Absorption of Pen G

A

IV or IM because unstable in gastric acid - destroyed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Absorption of Nafcillin, ticarcillin, piperacillin

A

IV or IM because poor GI absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pen V, Dicloxacillin, Ampicillin: special consideration when administered

A

can be given orally but food interferes with absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Elimination of Penicillin drugs

A
All unchanged in the urine
Rapid elimination (30mins- 1.5hr)
All except for amoxicillin have some biliary excretion
Ticarcillin and piperacillin: biliary excretion is increased with renal deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AE for penicillin drugs

A

Common:
NVD (increased risk with amoxicillin), Allergic reactions, phlebitis- inflammation of veins (Ticarcillin and piperacilin)
Rare:
neutropenia (pen G, nafcillin, piperacillin)
CNS effects (confusion, seizures)
Hyperkalemia (pen G K+)
dizziness, tinnitus, headache (Pen G procaine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Special considerations for Penicillins

A

Increased risk of rash with amoxicillin with allopurinol
Pen G and V decrease effectiveness of birth control pills
Colestipol (cholesterol) decrease Pen V absorption
Probenecid (gout) increases plasma levels with pen G and V

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cephalosporins First generation

A
very active against gram (+) aerobic cocci
Pen-sensitive staph and strep
NOT active against enterococci
little g(-)
Cefazolin
Cephalexin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Cephalosporins Second generation

A
active against g(+) aerobic cocci but not as much as 1st gen
but has better g(-)
mouth but not GI anaerobes 
Loracarbef
Cefonicid
cefaclor
cefuroxime
cefprozil
cefazolin (parenteral)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

3rd generation cephalosporin

A
inferior to 2nd and 1st for g(+) 
good against g(-)
broad coverage of enterobacteria
NO GI anaerobes
cefixime
cefotaxime
Cefoperaxone (doesn't go to CNS & biliary excretion)
Ceftriaxone (biliary excretion- reversible obstructive toxicity)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

4th generation cephalosporin

A

less potent than 1st gen but more than 3rd gen against g(+) EXCELLENT against g(-)
better than 3rd gen!
cefeprime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cephamycins

A

Cefoxitin
not “true” 2nd generation
less active against G(+) cocci
CAN GO AGAINST SOME ENTEROBACTERIA
Used: anaerobic/aerobic infections of the skin/ soft tissue
intra-abdominal or gynecological surgical prophylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical use of first generation cephalosporin

A

uncomplicated, community acquired skin and soft tissue infections and UTI
respiratory infection by PEN sensitive bacteria
surgical wound prophylaxis (parenteral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Clinical use of 2nd generation cephalosporin

A

community acquired respiratory infection

uncomplicated UTI by E.coli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

clinical use of 3rd generation cephalosporin

A

hospital acquired gram (-) infections
all kinds of complicated community acquired infections
lyme disease, severe shigella, typhoid fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

clinical use of 4th gen cephalosporin

A

moderate to sever nosocomial acquired infections
uncomplicated and complicated UTI, skin and soft tissue infections
Pneumonia bacteremia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

MoA of cephalosporins

A

inhibit transpeptidase PBP1a, 1b, PBP3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Ceftobiprole Medocarila

A

broad spectrum cephalosporin derivative
high affinity for PBP2a for MRSA and PBP2x for resistant strep.
knocks everything down

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

T1/2 for 1st gen & 4th gen cephalosporins

A

1-2 hours

4th gen readily penetrate the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

T1/2 for 2nd gen & 3rd gen cephalosporins

A

wide range: 1-8hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

AE for cephalosporins:

A

Common: NVD, allergic rxns
ceftrioxone - reversible obstructive excretion
Rare: blood cell problems, granulocytopenia (bone marrow suppression), renal tubular necrosis (most are excreted through the kidneys)

30
Q

Special considerations for cephalosporins

A

MTT (methytetrathiazole) increased effects of warfarin.
alcohol intolerance because acetaldehyde dehydrogenase
increased nephrotoxicity with ahminoglycosides
probenecid (gout) increase plasma levels
milk protein hypersensitivity

31
Q

B-lactamase inhibitors

A

not used separated because have weak abx activity- potent inhibitors of B-lactamases
Drugs:
Clavulinic acid
Sulbactam
Tazobactam
Restore the abx properties of aminopenicillins, piperacillin and ticarcillin.

32
Q

MoA of B-lactamase inhibitors

A

covalently bonds with B-lactamases to make table intermediates - > prevents interactions with penicillins

33
Q

Excretion of B-lactamase inhibitors

A
they are all excreted in urine 
Clavulinic acid also secreted as metabolites in lungs and feces
sulbactam minor biliary excretion
low CNS penetration
absorbed in GI tract
34
Q

names some Carbapenems

A

Imipenem-cilistatin
Meropenem
Ertapenem
Doripenem

35
Q

Carbapenem spectrum

A

broad spectrum - g(-) and g(+) aerobic and anaerobic
better than pen G = better g(+)
not active against MRSA or C.difficile

36
Q

Use of carbapenem

A

moderate to severe nosocomial and polymicrobial infections = imipenem, meropenem, doripenem
mild to moderate community acquired infections = ertapenem NOT FOR NOSOCOMIAL

37
Q

MoA of carbapenems

A

inhibit PBP activity
affinities for Imipenem: PBP2»PBP1a»PBP3a
Meropenem, Ertapenem: PBP2, PBP3>PBP1a, 1b
Doripenem: high affinity for PBP1a, 1b, PBP2, 3, 4
NO affinity for PBP2a (MRSA) or PBP2x (resistant strep)

38
Q

Absorption/excretion of Carbapenems

A

Parenterally - poor stability in GI and poor absorption
Short half life (1hr)
most excreted unchanged in glomerular filtration

39
Q

How is imipenem excreted?

A

It is hydrolyzed at the brush borders of renal tubules by dehydropeptidase.

  • *must be given with cilistatin (DHPI inhibitor) or else metabolites are NEPHROTOXIC
  • also enhances the ability of imipenem
40
Q

AE of carbapenems

A

blood and clotting problems with imipenem
seizures with imipenem
okay for pregnancy

41
Q

special considerations with carbapenems

A
  • cross reactive with other B-lactam abx
  • any drug cause causes decrease in glomerular filtration
  • increased risk of seizures with imipenem and ganciclovir
  • Probenecid increases serum levels with meropenem
  • Ertapenem diluted with lidocaine is contraindicated in pots with hypersensitivity to amide local anesthetics
42
Q

Monobactam spectrum

A

Gram negative aerobic bacteria that are resistant to B-lactamases
DOES NOT WORK WITH G(+) anaerobic

43
Q

Clinical use of monobactams

A

Used as Azetreonam.
UTI’s, lower respiratory infections, skin…
patients with severe allergy to penicillins and cephalosporins

44
Q

MoA of monobactams

A

binds to and inhibits PBP3 in g(-) bacteria

changes cell shape structure so that it no longer works`

45
Q

Absorption/elimination of monobactams

A

not absorbed by GI tract
glomerular filtration elimination
adjusted to renal failure

46
Q

AE of monobactams

A

Elevated liver enzymes

47
Q

Special considerations for monobactams

A

B-lactamase inducing abx may increase resistance to Aztreonam

48
Q

Vancomycin spectrum

A

G(+) aerobic or anaerobic

not effective against Listeria (which is G+)

49
Q

Clinical uses of vancomycin

A

prophylaxis: surgical implant, MSSA or MRSA in hemodialysis, respiratory/GI/ Genitourinary procedures
C. difficile
Staph. enterocolitis

50
Q

MoA of vancomycin

A

Binds with high affinity to D-ala, D-ala terminus
DOES NOT interact with PBPps
prevents interaction with transglycosylase blocking growth of peptidoglycan chain

51
Q

Absorption/ elimination of vancomycin

A

poor oral absorption ->IV
readily goes into CSF
excreted unchanged in urine -> depends on CrCl
Long half life (6h) with 2-4x MIC, PAE last 2-7hr
watch the CrCl

52
Q

AE of vancomycin

A

nephrotoxicity

RED MAN SYNDROME (immediate reaction: severe hypotension and cardiac arrest due to fast IV infusion)

53
Q

special considerations for vancomycin

A

increased risk or nephrotoxicity with ahminoglycosides, bacitracin, polymixin B.
flushing with anesthetics
neuromuscular blockade increase with muscular relaxants

54
Q

Telavancins are…

A

semi-synthetic analog of vancomycin

55
Q

Telavancin spectrum

A

G(+). effective against MSSA and MRSA.
more potent than vancomycin for decreasing biofilm formation.
effective for E. faecium and faecalis

56
Q

Clinical use of Telavancin

A

skin and skin structure infections by susceptible strains.

Nosocomial pneumonia

57
Q

MoA of Telavacin

A

1) same as vancomycin: binds to D-ala, D-ala terminus to stop inhibiting peptidoglycan chains
2) Lipid side chain acts as a detergent to destroy membrane

58
Q

Excretion of Telavacin

A

LONG half life (9hrs) normal renal function
excreted in urine
high plasma protein binding

59
Q

AE of Telavacin

A

taste disturbance,

increase serum creatinine, low K

60
Q

Daptomycin spectrum

A

aerobic and anaerobic G(+).

effective against stop (MSSA/MRSA) and strep A, D

61
Q

Clinical use of Daptomycin

A

same as Telavancin:
skin and skin structure infections.
Nosocomial pneumonia

62
Q

MoA of Daptomycin

A

Concentration dependent - Ca++
Daptomycin inserted into the lipid bilayer (creates a channel) and then depolarizes the membrane with K+ efflux resulting in rapid cell death

63
Q

Daptomycin Elmination

A

Long half life (8-9 hours) & PAE (5-10hr)

unchanged in urine. clearance decreased in obese pts (highly lipid)

64
Q

AE of daptomycin

A

Regular: NVD, injection site, headache, fever,

INSOMINIA

65
Q

special considerations of daptomycin

A

interactions with HMG-CoA reductase inhibitors (statins): increases risk for myopathy.
dose change for hemodialysis

66
Q

Polymyxins examples

A

Polymyxin B - parenteral
Colistin (topical and oral)
Colistimethate (oral)

67
Q

spectrum of polymyxins

A

G(-) esp. for p. aeruginosa

NOT FOR g(-) or g(+) aerobic cocci or g(+) aerobic bacilli

68
Q

Clinical use for polymyxins

A

when nothing else works

69
Q

MoA of polymyxins

A

binds to and neutralizes LPS (inflammation). reacts with lipid A (part of LPS) to make pore-like structures to disrupt membrane.

70
Q

Elimination of polymyxins

A

highly bound to membrane lipids in many tissues-> slow release of drug from bound tissue
half like moderate (3.5-6h)
unchanged in urine

71
Q

AE of polymyxins

A
Nephrotoxicity (reversible)
tubular necrosis (acute)
neuromuscular blockade (like daptomycin and vancomycin)